gp100/GM-CSF melanoma vaccine (University of Wisconsin)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namegp100/GM-CSF melanoma vaccine (University of Wisconsin)
Drug Alias Namemelanoma gene therapy 3 (University of Wisconsin)
ClassificationCell and gene therapy > Cell therapyBiologics > Antigen
Mechanisms of ActionMacrophage colony stimulating factor 2 Gene transference
TargetsMacrophage colony stimulating factor 2
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Wisconsin-Madison
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A